2026年1月23日,股价目标有所改变,各大公司在不断变化的部门前景中作出各种修订。 On January 23, 2026, stock price targets shifted, with mixed revisions across major firms amid changing sector outlooks.

2026年1月23日,分析师价格目标在各大股票中发生了转变:阿伯特实验室面临多次下调,目标范围从125美元到144美元,而abrdn,Adient,Allison Transmission,Associated Banc,American Axle,Banc of California,BancFirst,Barclays,Biogen和Caterpillar则从各个公司获得了升级. On January 23, 2026, analyst price targets shifted across major stocks: Abbott Laboratories faced multiple downward revisions, with targets ranging from $125 to $144, while abrdn, Adient, Allison Transmission, Associated Banc, American Axle, Banc of California, BancFirst, Barclays, Biogen, and Caterpillar received upgrades from various firms. ARM看到大幅削减,预订、B&M欧洲价值零售和Broadridge也降低。 ARM saw a significant cut, and Booking, B&M European Value Retail, and Broadridge were also lowered. 总的说来,人们的情绪仍然好坏参半,各公司根据不同部门的前景调整目标。 Overall, sentiment remained mixed, with firms adjusting targets amid varied sector outlooks.